1. Jerusalem ID Card Key Facts Population 2002: 680,300 Forecast Population in 2020: 946,500 HUJ (80 years): 24,000 students,10,000 graduates 1100 Academics

2. THE SHERMAN BUILDING FOR RESEARCH ADMINISTRATION Edmond J.Safra Campus, Givat Ram R&D

3. ARD Prospecting new Funding sources Distributing Information to Researchers * controls expenses according to appropriate items * is responsible for the scientific report * is responsible for the financial report

4. RESEARCH PROJECTS IN THE HEBREW UNIVERSITY YEAR 2003 1, 157 NEW 3,200 IN OPERATION

5. FLUCTUATION IN RESEARCH FUNDS 72 74 76 78 80 82 84 86 1998/9 1999/2000 2000/1 year in millions of dollars 76 81 84 2001/2 82.5 84 2002/3 90 2004

6. EFFECTIVE ANNUAL RESEARCH INVESTMENT AT HUJ Grant/Centers Funds$ 83 Million Fellowship$ 14 Million Salaries $ 103 Million TOTAL$ 200 Million 30% of all Israeli civilian Research

7. Research Funds Sources 2003 22.5 18 23.5 10 8

8. Social sciences 12 % Medicine22 % Natural Sciences 29 % Agriculture 21 % Education 5 % Social Work 2% Law 1% Humanities 4 % Business Administration 1 % Dental Medicine 3 % DISTRIBUTION AMONG FACULTIES 2002/03

9. INTERNAL RESEARCH GRANTS 2002/3 Support for Basic Research $ 2,400,000 Support for Applied Research $ 700,000 Total $ 3,100,000 Equipment 1,500,000 Grand Total 4,600,000

11. ICNC BIS

12. Talmud says “The traditions cited by Rabbi Sheshet are not subject to doubt as he is a blind man” (Talmud Yerushalmi, Shabbat 1b ).

13. 2. Sampled signals 3. Interpreter 4. Robotic arm 1. Recordings and telemetry 5. Desired Target

15. \ USA, Holland, Israel, Denmark France, UK, Germany 1.5 1.0 0.5 IMPACT RELATIVE TO THE FIELD Computer Sciences, Material Sciences

16. 15 Academics high scientific rank 40 M US $ investment in Heavy equipment-infrastructure in the next 5 years DECISION

17. http://nanoscience.huji.ac.il/ The Center for Nanoscience and Nanotechnology Micha Asscher and Scientific american 2004

18. boron, carbon, nickel and hydrogen MOTOR 144 o

19. FUEL

20. BIOINFORMATICS http://www.cbc.huji.ac.il/ The Sudarsky Center for Computational Biology

21. Distribution of MSc. and PhD. Students in Biotechnology Related Fields, by Institute Hebrew U Technion Tel Aviv Weizmann Haifa Ben Gurion Bar Ilan (9%) 389 (1%) 34 (5%) 236 (28%) 1,246 (3%) 128 (43%) 1,667 (11%) 485 Source: Vatat - The Planning and Budgeting Committee

22. Ben Gurion 0500100015002000 Weizmann Haifa Bar Ilan Tel Aviv Technion Hebrew U MSc. and PhD. Students in Biotechnology Related Fields by Institute (2001) agriculture Source: Vatat - The Planning and Budgeting Committee

24. PRIZES PRIZES Encouraging Excellence in Research Birk Kaye Abisch Barenholz Polonsky

25. Universities Fuel Israel’s Industries Universities Fuel Israel’s Industries

26. Yissum, the Technology Transfer Company (TTC) is responsible for recognizing and managing the IP assets of the Hebrew University in Jerusalem. Yissum’s mission is to help turn science into tangible products, for society's use and benefit, while generating income for the inventors and the University, to support research and education. 1) evaluating projects, 2) patenting new inventions, 3) developing licensing strategies, 4) negotiating licensing agreements, 5) assisting and supporting researchers who wish to establish companies to develop and manufacture products based on their inventions, and 6) coordinating joint research between inventors and industrial partners.

27. It is general policy that rights to IP resulting from government-sponsored research at universities would be assigned to the universities. The Technology Transfer Process 1) Yissum receives innovation disclosures from faculty, staff and students.(HU rules). 2) Disclosures are evaluated for their commercial potential. 3) The invention is reviewed with the inventor to learn about potential applications. 4) Develop a licensing strategy, consider the technical and market risks and decide whether to patent the invention. Yissum can decide not to pursue a commercialization process, the inventor is notified and entitled to apply for a patent independently and at his own expense. The IP however, remains the property of the Hebrew University.

28. Acquired bureaucratic deficiency syndrome Material with potential to become a revolutionary medicine for treating AIDS was found in 1996 by Prof. Zeev Trainin, Trainin and his team injected the material into mice that were infected with an AIDS-like disease and the disease disappeared almost in some of the mice. The Industry and Trade Ministry agreed to provide the necessary financing through one of its "high-tech incubator" funds, but the Agriculture Ministry refused to waive its intellectual property rights. Like children, the two ministries squabbled over who owned the rights and in the meantime, the entire testing process came to a halt. Trainin succeeded in interesting an investor from Britain in the drug, but then the Justice Ministry ruled that the Agriculture Ministry could not enter into direct contractual ties with foreign investors

29. Technology Transfer Services Different inventions require different approaches and strategies of commercialization, For example, establishing start-up entities and incubator companies vis a vis licensing out IP rights. As part of the commercialization process our assortment of available services includes: patent applications and enforcement, legal advice, negotiation of agreements, business development and creating marketing materials.

30. Royalties distribution Until 2001, royalties distribution was as follows: 1/3 – To the Researchers 1/3 – To Yissum 1/3 – To the HU, as research share (to research budgets) As of January 2001, new royalties distribution formula is used, as follows: 20% - To the Researchers 40%- To Yissum and the HU 20% - To the HU, as research share (to research budgets)

31. No. of Employees January 9, 2005

36. http://www.yissum.co.il http://www.yissum.co.il founded 1964 Around 35 companies Ex Libris, HumanEyes Technologies Ltd. Red Herring' chose MobilEye as top innovative company for 2004, NovaGali AQ10 BIOFUNGICIDE CHERRY TOMATOES -Cocktail Hybrids DEXANABINOL DOXIL EXELON (rivastigmine tartrate)capsules RAM ONION SILKIS The first eye drop which is capable of abolishing the conjunctival damage in moderate or severe dry eye symptomSILKIS SUPRA-VIR